Related Experiment Videos
Ubiquitin-protein ligases in muscle wasting: multiple parallel pathways?
1Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA. slecker@caregroup.harvard.edu
Current Opinion in Clinical Nutrition and Metabolic Care
|April 12, 2003
Summary
Muscle atrophy involves increased protein breakdown through the ubiquitin-proteasome pathway. Key ubiquitin ligases, atrogin-1/MAFbx and MURF-1, are critical in this process, with multiple pathways potentially involved.
Area of Science:
- Muscle physiology
- Molecular biology
- Biochemistry
Background:
- Muscle wasting (atrophy) is linked to increased protein breakdown.
- The ubiquitin-proteasome pathway is a key mechanism in muscle mass loss.
- Understanding the specific enzymes involved in muscle atrophy has been challenging.
Purpose of the Study:
- To review the current understanding of the ubiquitin-proteasome pathway in muscle atrophy.
- To identify key ubiquitin-conjugating enzymes involved in muscle wasting.
- To explore the complexity of ubiquitination in atrophying muscles.
Main Methods:
- Review of animal models of muscle wasting.
- Analysis of recent experimental findings on ubiquitin-protein ligases.
- Inclusion of in-vitro studies on the N-end rule pathway.
Main Results:
- Two novel ubiquitin-protein ligases (E3s), atrogin-1/MAFbx and MURF-1, are crucial for muscle atrophy development.
- The N-end rule pathway enzymes E2(14k) and E3alpha are implicated in muscle wasting.
- Multiple ubiquitin conjugation pathways appear to be activated simultaneously in atrophying muscle.
Conclusions:
- Multiple ubiquitin conjugation pathways likely operate in parallel during muscle atrophy.
- These pathways may target specific classes of muscle proteins for degradation.
- Future research should focus on identifying E3 targets and inhibitors.